New therapeutic agents for metastatic colorectal cancer: literature review-Reference-Cited by-同舟云学术

New therapeutic agents for metastatic colorectal cancer: literature review

Published:2018-12-27 Issue:4 Volume:8 Page:34-46
ISSN:2413-0583
Container-title:Colorectal Oncology
language:
Short-container-title:Onkol. koloproktol.

Author:

Zabelin M. V.¹,Gordeev S. S.²,Kochkina S. O.²,Kostin A. A.¹,Fedenko A. A.³,Petrov L. O.⁴,Gameeva E. V.³

Affiliation:

1. National Medical Research Radiology Center, Ministry of Health of Russia

2. N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

3. P.A. Herzen Moscow Oncology Research Institute — branch of the National Medical Radiology Research Center, Ministry of Health of Russia

4. A.F. Tsyb Medical Radiological Research Center — branch of the National Medical Research Radiology Center, Ministry of Health of Russia

Publisher

Publishing House ABV Press

Subject

Automotive Engineering,General Medicine

Reference72 articles.

1. Lukashina M.I., Smirnova A.V., Aliev V.A. et al. Dendritic cell vaccines for colorectal cancer therapy. Vestnik RONC im. N.N. Blokhina RAMN = Journal of N.N. Blokhin Russian Cancer Research Center 2008;19(3):35–42. (In Russ.).

2. Akylbekova G.A., Abdylaev G.A. Current possibilities of chemotherapy for colorectal cancer (literature review). Izvestiya vuzov = Proceedings of Universities 2013;5:53–7. (In Russ.).

3. Smagulova K. Assessing quality of life in patients treated for metastatic colon and rectal cancer. Uspekhi sovremennoy nauki = Advances of Modern Science 2017;1(6):81–3. (In Russ.).

4. Fedyanin M.Yu., Tryakin A.A., Tjulandin S.A. Targeted drugs in the treatment of colon cancer. Onkologiya, gematologiya i radiologiya = Oncology, Hematology, and Radiology 2012;3:30–6. (In Russ.).

5. Hoff P.M., Ansari R., Batist G. et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol 2001;19(8):2282–92. PMID: 11304782. DOI: 10.1200/JCO.2001.19.8.2282.